Tuesday, June 21, 2016

UPDATE 2-Impax buys generic drugs from Teva, Allergan for $586 mln

June 21 (Reuters) - Impax Laboratories Inc said it

would buy a portfolio of generic drugs from Teva Pharmaceutical

Industries Ltd and Allergan Plc for about $586

million.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)